The infectious disease specialist is often called upon to provide leadership in designing strategies for the prevention, control, and treatment of influenza. Because the threat of an influenza pandemic is unfortunately very real, it is also very important that these specialists be able to extrapolate the most relevant lessons from seasonal epidemics and apply them to pandemic mitigation strategies. Recent advances in the understanding of influenza transmission provide valuable information for the design of appropriate containment strategies, both pharmacological and nonpharmacological. Nonpharmacological community mitigation measures are expected to play a key role in a pandemic scenario, requiring the full attention of the infectious disease specialist. The best use of antivirals for both prophylaxis and treatment of influenza in a pandemic is the subject of intense scrutiny. Data are emerging on resistance and susceptibility of candidate pandemic strains in both approved and investigational agents. This program will address these topics via a series of lectures by experts in the field, followed by a panel discussion that will further clarify the issues.

Health care providers involved in the treatment of those at risk for seasonal and pandemic influenza.


This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint sponsorship of the NYU Post-Graduate Medical School and Lenox Hill Hospital. The NYU Post-Graduate Medical School is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation Statement
The NYU Post-Graduate Medical School designates this educational activity for a maximum of 2 AMA PRA Category 1 Credits™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

The NYU Post-Graduate Medical School adheres to ACCME Essential Areas and Policies, including the Standards for Commercial Support regarding industry support of continuing medical education. In order to resolve any identified conflicts of interest, disclosure information is provided during the planning process to ensure resolution of any identified conflicts. Disclosure of faculty and commercial relationships, as well as the discussion of unlabeled or unapproved use of any drug, device, or procedure by the faculty, is made known below.

Martin Cetron, MD

Andrew T. Pavia, MD

Michael L. Tapper, MD

Robert A. Weinstein, MD

The independent reviewer of this activity has no real or apparent conflicts of interest to report.

Internet Activity

Windows

Macintosh

Internet Connection


For further information about the NYU School of Medicine privacy and confidentiality policy, click here: http://www.med.nyu.edu/contact/privacy.html

Unless otherwise noted, all documents accessed from this page are viewed as a precious resource of NYU and are copyright, NYU Post-Graduate Medical School, all rights reserved. The presentation by Dr. Martin Cetron is a resource of the Centers for Disease Control and Prevention, and is Copyright, Centers for Disease Control and Prevention, all rights reserved.